Literature DB >> 5284360

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

J R Vane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5284360     DOI: 10.1038/newbio231232a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN: 0090-0028


× No keyword cloud information.
  1555 in total

1.  A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.

Authors:  L C Hamilton; I Vojnovic; T D Warner
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Endothelium-dependent relaxation followed by contraction mediated by NK(1) receptors in precontracted rabbit intrapulmonary arteries.

Authors:  H Shirahase; M Kanda; K Kurahashi; S Nakamura
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

Review 3.  Simple analgesics.

Authors:  J Parkhouse
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.

Authors:  B J Whittle
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

5.  Proceedings: Dissociation of bacterial pyrexia from prostaglandin E activity.

Authors:  A Artunkal; E Marley; J D Stephenson
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

Review 6.  Prostaglandins in reproductive physiology.

Authors:  G M Craig
Journal:  Postgrad Med J       Date:  1975-02       Impact factor: 2.401

7.  Cyclo-oxygenase-2 inhibition and exacerbation of myocardial dysfunction--protection with nitric oxide?

Authors:  Gordon Letts
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 8.  Aspirin and ACE-inhibitors: for wedding or funeral?

Authors:  I M Barbash; S Gottlieb; U Goldbourt; S Behar; J Leor
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

9.  Bufexamac: a review of its pharmacological properties and therapeutic efficacy in inflammatory dermatoses.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 10.  Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different?

Authors:  M L Kowalski
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.